Literature DB >> 33396408

Multi-Omics Characterization of Inflammatory Bowel Disease-Induced Hyperplasia/Dysplasia in the Rag2-/-/Il10-/- Mouse Model.

Qiyuan Han1, Thomas J Y Kono2, Charles G Knutson3, Nicola M Parry4, Christopher L Seiler5, James G Fox3, Steven R Tannenbaum3, Natalia Y Tretyakova5.   

Abstract

Epigenetic dysregulation is hypothesized to play a role in the observed association between inflammatory bowel disease (IBD) and colon tumor development. In the present work, DNA methylome, hydroxymethylome, and transcriptome analyses were conducted in proximal colon tissues harvested from the Helicobacter hepaticus (H. hepaticus)-infected murine model of IBD. Reduced representation bisulfite sequencing (RRBS) and oxidative RRBS (oxRRBS) analyses identified 1606 differentially methylated regions (DMR) and 3011 differentially hydroxymethylated regions (DhMR). These DMR/DhMR overlapped with genes that are associated with gastrointestinal disease, inflammatory disease, and cancer. RNA-seq revealed pronounced expression changes of a number of genes associated with inflammation and cancer. Several genes including Duox2, Tgm2, Cdhr5, and Hk2 exhibited changes in both DNA methylation/hydroxymethylation and gene expression levels. Overall, our results suggest that chronic inflammation triggers changes in methylation and hydroxymethylation patterns in the genome, altering the expression of key tumorigenesis genes and potentially contributing to the initiation of colorectal cancer.

Entities:  

Keywords:  colorectal cancer; dysplasia; hydroxymethylome; hyperplasia; inflammatory bowel disease; methylome; multi omics analysis and integration; transcriptome

Mesh:

Substances:

Year:  2020        PMID: 33396408      PMCID: PMC7795000          DOI: 10.3390/ijms22010364

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  104 in total

Review 1.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

2.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

3.  Replication timing-related and gene body-specific methylation of active human genes.

Authors:  Dvir Aran; Gidon Toperoff; Michael Rosenberg; Asaf Hellman
Journal:  Hum Mol Genet       Date:  2010-11-26       Impact factor: 6.150

Review 4.  Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancers.

Authors:  Victoria Valinluck; Lawrence C Sowers
Journal:  Cancer Res       Date:  2007-06-15       Impact factor: 12.701

5.  DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice.

Authors:  Yue Guo; Renyi Wu; John M Gaspar; Davit Sargsyan; Zheng-Yuan Su; Chengyue Zhang; Linbo Gao; David Cheng; Wenji Li; Chao Wang; Ran Yin; Mingzhu Fang; Michael P Verzi; Ronald P Hart; Ah-Ng Kong
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

6.  Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer.

Authors:  Xia Zhang; Qiong Wu; Lu Gan; Guan-Zhen Yu; Rui Wang; Zi-Shu Wang; Jie-Jun Wang; Xi Wang
Journal:  Med Oncol       Date:  2013-01-10       Impact factor: 3.064

7.  Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice.

Authors:  S E Erdman; V P Rao; T Poutahidis; A B Rogers; C L Taylor; E A Jackson; Z Ge; C W Lee; D B Schauer; G N Wogan; S R Tannenbaum; J G Fox
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

8.  5-halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2).

Authors:  Victoria Valinluck; Pingfang Liu; Joseph I Kang; Artur Burdzy; Lawrence C Sowers
Journal:  Nucleic Acids Res       Date:  2005-05-25       Impact factor: 16.971

Review 9.  The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges.

Authors:  Andrew P Hutchins; Diego Diez; Diego Miranda-Saavedra
Journal:  Brief Funct Genomics       Date:  2013-08-12       Impact factor: 4.241

10.  DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3.

Authors:  Xue Zhang; Jing Han; Li Feng; Lianghui Zhi; Da Jiang; Bin Yu; Zhenya Zhang; Bo Gao; Cong Zhang; Meng Li; Lianmei Zhao; Guiying Wang
Journal:  Carcinogenesis       Date:  2021-02-11       Impact factor: 4.944

View more
  3 in total

Review 1.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

2.  HLA Class II Polymorphisms Modulate Gut Microbiota and Experimental Autoimmune Encephalomyelitis Phenotype.

Authors:  Shailesh K Shahi; Soham Ali; Camille M Jaime; Natalya V Guseva; Ashutosh K Mangalam
Journal:  Immunohorizons       Date:  2021-08-11

3.  Quantitative Proteogenomic Characterization of Inflamed Murine Colon Tissue Using an Integrated Discovery, Verification, and Validation Proteogenomic Workflow.

Authors:  Andrew T Rajczewski; Qiyuan Han; Subina Mehta; Praveen Kumar; Pratik D Jagtap; Charles G Knutson; James G Fox; Natalia Y Tretyakova; Timothy J Griffin
Journal:  Proteomes       Date:  2022-04-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.